KMI169

MedChem Express

KMI169

5

Research Use Only

98.00

C31H31Cl2N7O2

604.53

KMI169 is a potent and selective bi-substrate inhibitor targeting the SAM and substrate binding pockets of KMT9 . KMT9 monomethylates histone H4 lysine 12 and controls the proliferation of prostate cancer cells. KMI169 can be used for the research of prostate cancer [1] .

NC1=C2C(C3=NN(C=C3Cl)CC4=CC=CC=C4)=CN([C@@H]5C[C@H](C6=CC(CN7CCC7)=CC=C6)[C@@H](O)[C@H]5O)C2=NC(Cl)=N1

2°C to 8°C

12352200